Literature DB >> 6170424

Pleural effusion in breast carcinoma: analysis of 122 cases.

R N Raju, C G Kardinal.   

Abstract

One-hundred-twenty-two patients with breast carcinoma and pleural effusion were analyzed for the laterality of effusion and survival. Ipsilateral effusion occurred in 83% of the patients. The median survival of these patients was six months after the onset of effusion. Systemic therapy is recommended even in the absence of other evidence of metastases.

Entities:  

Mesh:

Year:  1981        PMID: 6170424     DOI: 10.1002/1097-0142(19811201)48:11<2524::aid-cncr2820481130>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Prolonged pleural catheters in the management of pleural effusions due to breast cancer.

Authors:  Ozkan Demirhan; Cetin Ordu; Alper Toker
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

2.  Immunocytochemical identification of breast carcinoma cells in effusions using a monoclonal antibody.

Authors:  R Mariani-Costantini; S Ménard; C Clemente; E Tagliabue; M I Colnaghi; F Rilke
Journal:  J Clin Pathol       Date:  1982-09       Impact factor: 3.411

Review 3.  Lung metastases.

Authors:  C J Herold; A A Bankier; D Fleischmann
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

4.  Intrapleural adaptive immunotherapy for breast cancer patients with cytologically-confirmed malignant pleural effusions: an analysis of 67 patients in Kyoto and Shiga Prefecture, Japan.

Authors:  N Kan; H Kodama; T Hori; A Takenaka; T Yasumura; H Kato; H Ogawa; S Mukaihara; T Kudo; K Ohsumi
Journal:  Breast Cancer Res Treat       Date:  1993-09       Impact factor: 4.872

Review 5.  Metastatic Carcinoma in Effusions.

Authors:  Vinod B Shidham
Journal:  Cytojournal       Date:  2022-01-31       Impact factor: 2.345

6.  Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH).

Authors:  M Fiegl; A Massoner; M Haun; W Sturm; H Kaufmann; R Hack; J Krugmann; M Fritzer-Szekeres; K Grünewald; G Gastl
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

7.  Malignant pleural effusion in breast cancer 12 years after mastectomy that was successfully treated with endocrine therapy.

Authors:  Tsuyoshi Shinohara; Hiroyuki Yamada; Yoshiro Fujimori; Kiyofumi Yamagishi
Journal:  Am J Case Rep       Date:  2013-06-03

8.  Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions.

Authors:  Ben Davidson; Helene Tuft Stavnes; Arild Holth; Xu Chen; Yanqin Yang; Ie-Ming Shih; Tian-Li Wang
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

9.  Pleural catheters after thoracoscopic treatment of malignant pleural effusion: a randomized comparative study on quality of life.

Authors:  Francesco Petrella; Patrick Maisonneuve; Alessandro Borri; Monica Casiraghi; Stefano Donghi; Sava Durkovic; Niccolo Filippi; Domenico Galetta; Roberto Gasparri; Juliana Guarize; Giorgio Lo Iacono; Alessio Vincenzo Mariolo; Adele Tessitore; Lorenzo Spaggiari
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

10.  Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer.

Authors:  Nikolaos Barbetakis; Theodoros Antoniadis; Christodoulos Tsilikas
Journal:  World J Surg Oncol       Date:  2004-05-20       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.